These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20171736)

  • 1. Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.
    Biswas S; Zhao X; Mone AP; Mo X; Vargo M; Jarjoura D; Byrd JC; Muthusamy N
    Leuk Res; 2010 Jul; 34(7):925-31. PubMed ID: 20171736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
    Ong PS; Chan SY; Ho PC
    Int J Oncol; 2011 Jun; 38(6):1731-9. PubMed ID: 21455570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.
    Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW
    J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
    Duechler M; Stańczyk M; Czyz M; Stepnik M
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism.
    Bowling BD; Doudican N; Manga P; Orlow SJ
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
    Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
    Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of ascorbic acid and n-acetyl-L-cysteine on arsenic trioxide-mediated oxidative stress in human leukemia (HL-60) cells.
    Yedjou CG; Rogers C; Brown E; Tchounwou PB
    J Biochem Mol Toxicol; 2008; 22(2):85-92. PubMed ID: 18418892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.
    Doudican NA; Bowling B; Orlow SJ
    Leuk Res; 2010 Feb; 34(2):229-34. PubMed ID: 19540589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Bcr-Abl-specific antileukemic activity of arsenic trioxide (Trisenox) through glutathione-depletion in imatinib-resistant cells.
    Konig H; Härtel N; Schultheis B; Schatz M; Lorentz C; Melo JV; Hehlmann R; Hochhaus A; La Rosée P
    Haematologica; 2007 Jun; 92(6):838-41. PubMed ID: 17550858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
    Oncotarget; 2016 Dec; 7(50):83359-83377. PubMed ID: 27829220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
    Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
    Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
    Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
    Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines.
    Stępnik M; Ferlińska M; Smok-Pieniążek A; Gradecka-Meesters D; Arkusz J; Stańczyk M
    Med Oncol; 2012 Jun; 29(2):1161-72. PubMed ID: 21523454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.